Medicare Offers Wegovy and Zepbound for $50 a Month — but Not to the Patients Who Need Them Most
Since July 1, 2026, Medicare has let some beneficiaries buy the weight-loss drugs Wegovy, Zepbound and Foundayo for a flat $50 a month, instead of list prices